Industry Standard Research asked biopharma and pharmaceutical executives from North America, Europe, and Asia to rate more than three dozen Phase II-III CRO providers on staff, delivery, budget, loyalty, and more.*
Easy to work with
Technology for real-time access to data
Project manager quality
Study design expertise
Timely project communications
Appropriateness of change orders
Fill out the form to discuss your rare disease needs with us.